Implantable Cardioverter Defibrillator (ICD) Patients and Inhalation Aromatherapy

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

September 8, 2023

Primary Completion Date

November 29, 2024

Study Completion Date

February 15, 2025

Conditions
Implantable Cardioverter Defibrillator (ICD)AromatherapyAnxietyFatigue Symptom
Interventions
OTHER

Aromatherapy group

It is known that aromatherapy is used in symptom management in chronic diseases. When the literature is examined, it is seen that aromatherapy application is effective in relieving anxiety and fatigue in cardiovascular diseases. Currently, there is no symptom management method other than pharmacological treatment that is widely used or recommended by health professionals for ICD patients. The literature review reveals that there is no study examining the effect of lavender oil aromatherapy in relieving anxiety and fatigue in individuals with ICD implantation. In this context, the aim of this study is to determine the effect of aromatherapy applied by inhaling two drops for two minutes before going to bed for one month on anxiety and fatigue levels in individuals with ICD implantation.

Trial Locations (1)

4522

Turkish Ministry of Health, Adana City Training and Research Hospital, Adana

All Listed Sponsors
collaborator

The Scientific and Technological Research Council of Turkey

OTHER

lead

TC Erciyes University

OTHER

NCT06874777 - Implantable Cardioverter Defibrillator (ICD) Patients and Inhalation Aromatherapy | Biotech Hunter | Biotech Hunter